Contortamide - Compound Card

Contortamide

Select a section from the left sidebar

Contortamide

Structure
Zoomed Structure
  • Family: Plantae - Apocynaceae
  • Kingdom: Plantae
  • Class: Lipid
    • Subclass: Cerebroside
Canonical Smiles CCCCCCCCCCCCCCCCCCCCCCC[C@@H](C(=O)N[C@H]([C@@H]([C@@H](C/C=C/CCCCCCCCCC)O)O)COC1OC(CO)C(C(C1O)O)O)O
InChI InChI=1S/C48H93NO10/c1-3-5-7-9-11-13-15-16-17-18-19-20-21-22-23-24-26-28-30-32-34-36-41(52)47(57)49-39(38-58-48-46(56)45(55)44(54)42(37-50)59-48)43(53)40(51)35-33-31-29-27-25-14-12-10-8-6-4-2/h31,33,39-46,48,50-56H,3-30,32,34-38H2,1-2H3,(H,49,57)/b33-31+/t39-,40+,41-,42?,43-,44?,45?,46?,48?/m0/s1
InChIKey IQZHOUPDSLPBIM-FUMOLMOCSA-N
Formula C48H93NO10
HBA 10
HBD 8
MW 844.27
Rotatable Bonds 41
TPSA 189.17
LogP 8.45
Number Rings 1
Number Aromatic Rings 0
Heavy Atom Count 59
Formal Charge 0
Fraction CSP3 0.94
Exact Mass 843.68
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Tabernaemontana contorta Apocynaceae Plantae 761060

Showing of synonyms

  • Foudjo Melacheu G, Mfotie Njoya E, et al. (2021). Contortamide, a new anti-colon cancer cerebroside and other constituents from Tabernaemontana contorta Stapf (Apocynaceae). Natural product research,2021, 35(11), 1757-1765. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 844.27 g/mol

Anti-colon cancer

Absorption

Caco-2 (logPapp)
-5.79
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
69.42
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
9830.87

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
1.35
Plasma Protein Binding
70.23
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
-0.48
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Safe
Bioconcentration Factor
-227.42
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.1
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.91
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-17845731.53
Rat (Acute)
2.48
Rat (Chronic Oral)
4.35
Fathead Minnow
22535.31
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
2004238.61
Hydration Free Energy
-2.92
Log(D) at pH=7.4
4.96
Log(P)
13.83
Log S
-5.8
Log(Vapor Pressure)
-65873.68
Melting Point
74.55
pKa Acid
-416.62
pKa Basic
8.22

No predicted protein targets found for this compound.

Download SDF